UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$527M |
| 2 |
NXP Semiconductors
NXPI
|
+$500M |
| 3 |
Chevron
CVX
|
+$297M |
| 4 |
Suncor Energy
SU
|
+$296M |
| 5 |
CERN
Cerner Corp
CERN
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$956M |
| 2 |
SPDR Gold Trust
GLD
|
+$760M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$551M |
| 4 |
ExxonMobil
XOM
|
+$530M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$448M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.38% |
| 2 | Technology | 6.63% |
| 3 | Healthcare | 6.13% |
| 4 | Industrials | 5.09% |
| 5 | Consumer Discretionary | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6201
PUT
GSK
GSK
$103B
| $17K | ﹤0.01% |
+320
| New | +$16.2K |
|
6202
Immunic
IMUX
$191M
| $17K | ﹤0.01% |
11
+2
| +22% | +$3.66K |
|
6203
PUT
Johnson Controls International
JCI
$93.7B
| $17K | ﹤0.01% |
+400
| New | +$16.9K |
|
6204
Centrus Energy
LEU
$3.71B
| $17K | ﹤0.01% |
2,766
+2,751
| +18,340% | +$17K |
|
6205
Live Oak Bancshares
LOB
$2.02B
| $17K | ﹤0.01% |
798
-2,959
| -79% | -$62.7K |
|
6206
Larimar Therapeutics
LRMR
$432M
| $17K | ﹤0.01% |
314
-106
| -25% | -$5.26K |
|
6207
Lattice Semiconductor
LSCC
$18.5B
| $17K | ﹤0.01% |
2,413
-17,476
| -88% | -$124K |
|
6208
Lisata Therapeutics
LSTA
$10.4M
| $17K | ﹤0.01% |
219
+9
| +4% | +$624 |
|
6209
Marathon Digital Holdings
MARA
$4.4B
| $17K | ﹤0.01% |
1,023
+753
| +279% | +$18K |
|
6210
Magyar Bancorp
MGYR
$129M
| $17K | ﹤0.01% |
+1,529
| New | +$16.1K |
|
6211
Modine Manufacturing
MOD
$10.6B
| $17K | ﹤0.01% |
1,427
-11,044
| -89% | -$137K |
|
|
MTR
6212
Mesa Royalty Trust
MTR
$5.37M
| $17K | ﹤0.01% |
1,279
+779
| +156% | +$9.33K |
|
6213
Plexus
PLXS
$7.35B
| $17K | ﹤0.01% |
294
-5,537
| -95% | -$309K |
|
6214
Powell Industries
POWL
$7.8B
| $17K | ﹤0.01% |
1,440
-7,053
| -83% | -$83.9K |
|
6215
ProShares UltraPro Short MidCap400
SMDD
$1.94M
| $17K | ﹤0.01% |
17
-25
| -60% | -$24.4K |
|
6216
Soligenix
SNGX
$5.61M
| $17K | ﹤0.01% |
26
+18
| +225% | +$10.5K |
|
6217
United Bancorp
UBCP
$93.8M
| $17K | ﹤0.01% |
1,411
+1,085
| +333% | +$13.8K |
|
6218
ProShares Ultra Euro
ULE
$4.42M
| $17K | ﹤0.01% |
1,209
-7,541
| -86% | -$108K |
|
6219
Vivani Medical
VANI
$118M
| $17K | ﹤0.01% |
570
-60
| -10% | -$2.3K |
|
|
TCON
6220
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $17K | ﹤0.01% |
23
| – | – |
|
|
PGTI
6221
DELISTED
PGT, Inc.
PGTI
| $17K | ﹤0.01% |
1,583
-4,754
| -75% | -$52.4K |
|
|
EXPR
6222
DELISTED
Express, Inc.
EXPR
| $17K | ﹤0.01% |
93
+24
| +35% | +$4.96K |
|
|
NXGN
6223
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $17K | ﹤0.01% |
1,137
-6,144
| -84% | -$90.5K |
|
|
BLCM
6224
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $17K | ﹤0.01% |
140
+44
| +46% | +$5.76K |
|
|
IVC
6225
DELISTED
Invacare Corporation
IVC
| $17K | ﹤0.01% |
1,428
-4,350
| -75% | -$52.2K |
|
Similar funds
UBS Group's Q1 2017 Portfolio in Review
As of Q1 2017, UBS Group held 8,532 positions worth $183B, up 1.2% from $181B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $8.15B in Q1 2017, closing 787 positions and reducing 3,714 holdings. Its most notable exit was American Capital Ltd, an estimated $114M position sold in full.
By sector, the portfolio is most concentrated in Financials at 7.4% of assets, up from 7% a quarter earlier, followed by Technology and Healthcare.
Against the trend, UBS Group opened a new position in Deutsche Bank Aktiengesellschaft worth $33.3M.
- UBS Group's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 14,119,827 shares worth $33.3M.
- UBS Group added most to iShares Core MSCI EAFE ETF in Q1 2017, an estimated $527M increase.
- UBS Group's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $956M.
- UBS Group fully exited American Capital Ltd in Q1 2017, selling an estimated $114M.
- UBS Group's ten largest holdings make up 15% of its $183B portfolio in Q1 2017.
- UBS Group opened 702 new positions and closed 787 in Q1 2017.
- UBS Group's portfolio value rose 1.2% quarter-over-quarter to $183B.
Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.